Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Noninvasive prediction of cirrhosis in C282Y-linked hemochromatosis.

Beaton M, Guyader D, Deugnier Y, Moirand R, Chakrabarti S, Adams P.

Hepatology. 2002 Sep;36(3):673-8.

PMID:
12198660
2.

Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis.

Guyader D, Jacquelinet C, Moirand R, Turlin B, Mendler MH, Chaperon J, David V, Brissot P, Adams P, Deugnier Y.

Gastroenterology. 1998 Oct;115(4):929-36.

PMID:
9753496
3.

Serum ferritin level predicts advanced hepatic fibrosis among U.S. patients with phenotypic hemochromatosis.

Morrison ED, Brandhagen DJ, Phatak PD, Barton JC, Krawitt EL, El-Serag HB, Gordon SC, Galan MV, Tung BY, Ioannou GN, Kowdley KV.

Ann Intern Med. 2003 Apr 15;138(8):627-33. Erratum in: Ann Intern Med. 2003 Aug 5;139(3):235.

PMID:
12693884
4.

Assessment of silent liver fibrosis in hemochromatosis C282Y homozygotes with normal transaminase levels.

Beaton M, Adams PC.

Clin Gastroenterol Hepatol. 2008 Jun;6(6):713-4. doi: 10.1016/j.cgh.2008.02.024.

PMID:
18550006
5.

Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis.

Crawford DH, Murphy TL, Ramm LE, Fletcher LM, Clouston AD, Anderson GJ, Subramaniam VN, Powell LW, Ramm GA.

Hepatology. 2009 Feb;49(2):418-25. doi: 10.1002/hep.22650.

PMID:
19177571
6.

The effect of the metabolic syndrome, hepatic steatosis and steatohepatitis on liver fibrosis in hereditary hemochromatosis.

Adams LA, Angulo P, Abraham SC, Torgerson H, Brandhagen D.

Liver Int. 2006 Apr;26(3):298-304.

PMID:
16584391
7.

[Utility of various non-invasive methods for fibrosis prediction among Basque Country patients with phenotypic hemochromatosis].

Castiella A, Zapata E, Otazua P, Fernández J, Alustiza JM, Ugarte M, Legasa L, Galardi A, Ugalde A, Barredo I, Arriola JA.

Rev Esp Enferm Dig. 2008 Oct;100(10):611-4. Spanish.

PMID:
19119785
8.

Phenotype variation in C282Y homozygotes for the hemochromatosis gene.

Lazarescu A, Snively BM, Adams PC.

Clin Gastroenterol Hepatol. 2005 Oct;3(10):1043-6.

PMID:
16234052
9.

Reversibility of hepatic fibrosis in treated genetic hemochromatosis: a study of 36 cases.

Falize L, Guillygomarc'h A, Perrin M, Lainé F, Guyader D, Brissot P, Turlin B, Deugnier Y.

Hepatology. 2006 Aug;44(2):472-7.

PMID:
16871557
10.

Screening for hemochromatosis in asymptomatic subjects with or without a family history.

Powell LW, Dixon JL, Ramm GA, Purdie DM, Lincoln DJ, Anderson GJ, Subramaniam VN, Hewett DG, Searle JW, Fletcher LM, Crawford DH, Rodgers H, Allen KJ, Cavanaugh JA, Bassett ML.

Arch Intern Med. 2006 Feb 13;166(3):294-301.

PMID:
16476869
11.

Simple clinical variables predict liver histology in hepatitis C: prospective validation of a clinical prediction model.

Romagnuolo J, Andrews CN, Bain VG, Bonacini M, Cotler SJ, Ma M, Sherman M.

Scand J Gastroenterol. 2005 Nov;40(11):1365-71.

PMID:
16334447
12.

Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C.

Lackner C, Struber G, Liegl B, Leibl S, Ofner P, Bankuti C, Bauer B, Stauber RE.

Hepatology. 2005 Jun;41(6):1376-82.

PMID:
15915455
13.

Cirrhosis in hepatitis C virus-infected patients can be excluded using an index of standard biochemical serum markers.

Islam S, Antonsson L, Westin J, Lagging M.

Scand J Gastroenterol. 2005 Jul;40(7):867-72.

PMID:
16109665
14.

Hereditary hemochromatosis: effect of excessive alcohol consumption on disease expression in patients homozygous for the C282Y mutation.

Scotet V, Mérour MC, Mercier AY, Chanu B, Le Faou T, Raguénes O, Le Gac G, Mura C, Nousbaum JB, Férec C.

Am J Epidemiol. 2003 Jul 15;158(2):129-34.

PMID:
12851225
15.

Prediction of progression to cirrhosis by a glutathione S-transferase P1 polymorphism in subjects with hereditary hemochromatosis.

Stickel F, Osterreicher CH, Datz C, Ferenci P, Wölfel M, Norgauer W, Kraus MR, Wrba F, Hellerbrand C, Schuppan D.

Arch Intern Med. 2005 Sep 12;165(16):1835-40.

PMID:
16157826
16.

Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B.

Kim BK, Kim SA, Park YN, Cheong JY, Kim HS, Park JY, Cho SW, Han KH, Chon CY, Moon YM, Ahn SH.

Liver Int. 2007 Sep;27(7):969-76.

PMID:
17696936
17.

13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C.

Dinesen L, Caspary WF, Chapman RW, Dietrich CF, Sarrazin C, Braden B.

Dig Liver Dis. 2008 Sep;40(9):743-8. doi: 10.1016/j.dld.2008.01.013. Epub 2008 Mar 12.

PMID:
18339592
18.

Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA-treated patients with primary biliary cirrhosis.

Corpechot C, Poujol-Robert A, Wendum D, Galotte M, Chrétien Y, Poupon RE, Poupon R.

Liver Int. 2004 Jun;24(3):187-93.

PMID:
15189267
19.

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, Lok AS.

Hepatology. 2003 Aug;38(2):518-26.

20.

TGF-beta1 codon 25 gene polymorphism is associated with cirrhosis in patients with hereditary hemochromatosis.

Osterreicher CH, Datz C, Stickel F, Hellerbrand C, Penz M, Hofer H, Wrba F, Penner E, Schuppan D, Ferenci P.

Cytokine. 2005 Jul 21;31(2):142-8.

PMID:
15941661

Supplemental Content

Support Center